CY1119704T1 - Παραγωγα τρισακχαριτη, και η χρηση τους ως ανοσοενισχυτικα - Google Patents

Παραγωγα τρισακχαριτη, και η χρηση τους ως ανοσοενισχυτικα

Info

Publication number
CY1119704T1
CY1119704T1 CY20171101340T CY171101340T CY1119704T1 CY 1119704 T1 CY1119704 T1 CY 1119704T1 CY 20171101340 T CY20171101340 T CY 20171101340T CY 171101340 T CY171101340 T CY 171101340T CY 1119704 T1 CY1119704 T1 CY 1119704T1
Authority
CY
Cyprus
Prior art keywords
trisaccharide
derivatives
immunosuppressants
trisaccharides
adjuvant compositions
Prior art date
Application number
CY20171101340T
Other languages
English (en)
Inventor
Johannes Gernardus Mathias Marie Van Bree
Everardus Joannes Peter Maria Schenkelaars
Jouwert Anne Turkstra
Maria Aldegonda Jacoba Kriek
Robert Patrick Hof
Wilhelmus Martinus Maria Schaaper
Original Assignee
Immunovo B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovo B.V. filed Critical Immunovo B.V.
Publication of CY1119704T1 publication Critical patent/CY1119704T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά τη χρήση παραγώγων τρισακχαρίτη, τα οποία περιλαμβάνουν έναν υποκατεστημένο πυρήνα τρισακχαρίτη, ο οποίος πυρήνας τρισακχαρίτη είναι πλήρως υποκατεστημένος με ομάδες εστέρα λιπαρών οξέων, και προαιρετικά μια ή περισσότερες ανιονικές ομάδες ως ανοσοενισχυτικά, τα ίδια τα παράγωγα τρισακχαρίτη, μια μέθοδο για την παρασκευή τέτοιων τρισακχαριτών, τους τρισακχαρίτες που λαμβάνονται με μια τέτοια μέθοδο, τις ανοσοενισχυτικές συνθέσεις που περιέχουν τέτοια παράγωγα τρισακχαρίτη και ένα εμβόλιο ή κιτ που περιέχει τέτοιες ανοσοενισχυτικές συνθέσεις.
CY20171101340T 2010-06-11 2017-12-21 Παραγωγα τρισακχαριτη, και η χρηση τους ως ανοσοενισχυτικα CY1119704T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10165707A EP2397484A1 (en) 2010-06-11 2010-06-11 Trisaccharide derivates, and their use as adjuvants
PCT/NL2011/050393 WO2011155822A1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants
EP11725217.1A EP2580226B1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Publications (1)

Publication Number Publication Date
CY1119704T1 true CY1119704T1 (el) 2018-06-27

Family

ID=43734127

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171101340T CY1119704T1 (el) 2010-06-11 2017-12-21 Παραγωγα τρισακχαριτη, και η χρηση τους ως ανοσοενισχυτικα

Country Status (24)

Country Link
US (2) US9327020B2 (el)
EP (3) EP2397484A1 (el)
JP (2) JP6004586B2 (el)
KR (1) KR101929973B1 (el)
CN (1) CN103154013B (el)
AU (1) AU2011262606B2 (el)
BR (1) BR112012031440A2 (el)
CA (1) CA2802023C (el)
CY (1) CY1119704T1 (el)
DK (1) DK2580226T3 (el)
ES (1) ES2654156T3 (el)
HR (1) HRP20171947T1 (el)
HU (1) HUE035187T2 (el)
IL (1) IL223570A (el)
LT (1) LT2580226T (el)
MX (1) MX342946B (el)
NO (1) NO2580226T3 (el)
PL (1) PL2580226T3 (el)
PT (1) PT2580226T (el)
RS (1) RS56690B1 (el)
RU (1) RU2595717C2 (el)
SI (1) SI2580226T1 (el)
WO (1) WO2011155822A1 (el)
ZA (1) ZA201209395B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
CA2954043A1 (en) * 2014-07-24 2016-01-28 Litevax B.V. Carbohydrate ester adjuvants

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
GB8703128D0 (en) * 1987-02-11 1987-03-18 Donmarn Ltd Anti-scaling compounds
US5543505A (en) * 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
EP1138337A3 (en) * 1994-08-04 2003-03-26 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
ZA9711732B (en) * 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
JP3041799B1 (ja) * 1998-09-29 2000-05-15 株式会社微生物化学研究所 新規なアジュバント及びそれを用いたワクチン
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
ES2315777T3 (es) * 2005-12-01 2009-04-01 Wella Aktiengesellschaft Uso de poliester de di-u oligosacarido en productos para el peinado del cabello.
US9045516B2 (en) * 2007-04-16 2015-06-02 Suri Saranathan Iyer Synthetic ligands for the differentiation of closely related toxins and pathogens
WO2009140683A1 (en) * 2008-05-16 2009-11-19 Research Foundation Of The City University Of New York Living copolymer protein/peptide hybrids for biomedical applications
BRPI1007325A2 (pt) * 2009-02-02 2019-09-24 Otsuka Pharma Co Ltd "baixo peso molecular de polissulfatados derivados de ácido hialurônico e medicamentos que contenham o mesmo."
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Also Published As

Publication number Publication date
AU2011262606B2 (en) 2016-10-27
AU2011262606A1 (en) 2013-01-10
SI2580226T1 (en) 2018-04-30
CN103154013A (zh) 2013-06-12
PL2580226T3 (pl) 2018-05-30
EP3312188A1 (en) 2018-04-25
ES2654156T3 (es) 2018-02-12
RS56690B1 (sr) 2018-03-30
RU2595717C2 (ru) 2016-08-27
JP2016216471A (ja) 2016-12-22
MX342946B (es) 2016-10-18
KR101929973B1 (ko) 2018-12-18
LT2580226T (lt) 2018-02-26
ZA201209395B (en) 2014-05-28
HUE035187T2 (hu) 2018-05-02
PT2580226T (pt) 2018-01-05
EP2580226B1 (en) 2017-11-29
US9327020B2 (en) 2016-05-03
CA2802023A1 (en) 2011-12-15
DK2580226T3 (en) 2018-01-08
US20130273082A1 (en) 2013-10-17
WO2011155822A1 (en) 2011-12-15
RU2013100945A (ru) 2014-07-20
EP2580226A1 (en) 2013-04-17
HRP20171947T1 (hr) 2018-02-23
BR112012031440A2 (pt) 2017-04-18
CA2802023C (en) 2020-07-14
CN103154013B (zh) 2017-03-15
MX2012014422A (es) 2013-08-27
US20170057987A1 (en) 2017-03-02
JP6004586B2 (ja) 2016-10-12
EP2397484A1 (en) 2011-12-21
IL223570A (en) 2017-03-30
KR20130056273A (ko) 2013-05-29
NO2580226T3 (el) 2018-04-28
JP2013528211A (ja) 2013-07-08

Similar Documents

Publication Publication Date Title
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
CY1121776T1 (el) C17-αλκανοδιυλιο και παραγωγα αλκενοδιυλιου του ολεανολικου οξεος και μεθοδοι χρησης αυτων
CY1117956T1 (el) N3-αντικατεστημενα-n1-sulfonyl-5-fluoropyrimidinone παραγωγα
CY1116987T1 (el) Συμπυκνωμενα ιμιδαζολυλιμιδαζολια ως αντιϊικες ενωσεις
BR112012017831A8 (pt) micro-organismos produtores de ácido eicosapentaenoico, composições de ácido graxo e métodos de fabricação e uso dos mesmos
BR112013022397A2 (pt) vacinas combinadas com doses menores de antígeno e/ou adjuvante
CY1116791T1 (el) 4-αρυλ-ν-φαινυλ-1,3,5-τριαζιν-αμινες που περιεχουν μια ομαδα σουλφοξιμινης
CY1116958T1 (el) Υποκατεστημενες τριαζολοπυριδινες και η χρηση τους ως ττκ αναστολεις
EP3071229A4 (en) Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants
EA201300585A1 (ru) Иммуномодулирующие олигонуклеотиды
EA201890942A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
BR112012023950A2 (pt) formas cristalinas de um macrolídeo, e usos dos mesmos
EA201791744A2 (ru) Улучшенная липидная композиция
CY1123056T1 (el) Νεα μορφη χορηγησης της ρασεκαδοτριλης
BR112014001443A2 (pt) micro-organismos produtores de ácido eicosapentaenóico, composições de ácidos graxos e métodos de produção e usos dos mesmos
ECSP13012958A (es) Inhibidores de benzodioxano de la producción de leucotrieno.
BR112013020719A2 (pt) composições de derivados de bimatoprost tipo éster e métodos
MX2013002948A (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
CR20130385A (es) Cepas de saccharomyces cerevisiae aptas para la producción de levaduras de panificación osmotolerantes y que presentan una resistencia intrínseca a los ácidos orgánicos débiles, sus procedimientos de preparación y aplicaciones
BR112016030294A8 (pt) cepa de bactérias probióticas de lactobacillus e uma vacina de aves domésticas, composição, ovo de aves domésticas embrionado, kit, e, método de vacinação in ovo de aves domésticas
CY1118514T1 (el) Μεθοδος για την παρασκευη πεμετρεξιδης και αλατος λυσινης αυτης
BR112016010862A8 (pt) formas mórficas de ésteres de hexadeciloxipropil-fosfonato, seu método de preparo e composição compreendendo a dita forma mórfica
UY33668A (es) ?composiciones de las paredes celulares de ácido ribonucleico bacteriano, y métodos para elaborarlas y usarlas?.
CL2017001588A1 (es) Ácidos piridil-cicloalquil-carboxílicos sustituidos, composiciones que los contienen y usos de los mismos
CY1119704T1 (el) Παραγωγα τρισακχαριτη, και η χρηση τους ως ανοσοενισχυτικα